Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Megan Haggan 19/07/2016

innovation: candle, tungsten bulb, two modern light bulbs

Debbie Rigby takes a look at the latest research pertinent to community pharmacy Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesIn this double-blind trial, liraglutide, an analogue of human glucagon like peptide 1 (GLP-1), showed a lower rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Doctor of Pharmacy’ title announced

Dentists don't don't do a Masters to get the title, they do a Batchelor of Dental Surgery. I'm also pretty…

Red Dog

‘Doctor of Pharmacy’ title announced

Difference is a dentist does a Batchelor of Dental Surgery, and therefore are a Doctor

Red Dog

‘We need more pharmacists’

Oh noooooooo how could we ever have seen this coming?

Michael Hewson

‘We need more pharmacists’

You can't own a regional pharmacy and get PBS approval without living in the region. Problem solved.

Big Pharma

Research Roundup

Previous Ministers welcomed by pharmacy groups

Next Hear this: audio education

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Ministers welcomed by pharmacy groups

Next Hear this: audio education

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.